Phaseliss

Phaseliss Mesolifter

Premium skin remodelling · 3 ml

A stabilised, injectable, hyaluronic-acid-only CE Class III medical device for treating skin laxity.

Highlights

  • CE-marked Class III medical device
  • Contains only stabilised, ultra-pure hyaluronic acid
  • NONASEM technology and thixotropic production
  • Effective for up to 60 days on skin laxity
  • Intense hydration; helps reduce the appearance of fine lines
  • Supports skin elasticity for a brighter, smoother look

This product must be administered only by a physician or authorised healthcare professional.

Phaseliss Mesolifter is a stabilised, injectable, hyaluronic-acid-only product registered as a medical device, effective for up to 60 days in treating skin laxity. It can be used on its own or combined with other aesthetic treatments, and has opened up a new area in the bio-reshaping category among injectables.

NONASEM (Non-Disturbing Natural State Modification) technology preserves the natural structure of hyaluronic acid. Advanced thixotropic production creates a stable structure through ionic interaction between molecules, extending degradation time in the body and harmonising with the biological properties of the treated area, so the ultra-pure, biocompatible hyaluronic acid has a long-lasting effect.

The recommended technique is Multi-Aesthetic Points (MAPs): 5, 6 or 8 strategic points are marked on each side of the face and subcutaneous injections are performed symmetrically. The stabilised ultra-pure hyaluronic acid complex spreads within the skin, hydrating it and improving laxity. With MAPs, side effects such as bruising, redness and irritation are less likely.

Phaseliss Mesolifter must not be mixed with a dermal filler or a classic mesotherapy serum.

Treatment areas

  • Face
  • Neck
  • Décolleté
  • Hands
  • Wrinkled, tired, sun-damaged and dry skin
Standard filler
Thixotropic filler

Get product and pricing information for your clinic

Talk to our team about product training, samples and bulk orders.